Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors

    NEXT STORY
    Global Medical Devices Market Report 2019-2022 – A $521+ Billion Opportunity Analysis
    PREV STORY
    HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dupixent® (dupilumab): de nouvelles données pivotales montrant une amélioration significative des symptômes de l’œsophagite à éosinophiles ont été présentées pour la première fois lors de congrès scientifiques

    author_avatar
    NASDAQ Market News

    Sharp HealthCare to Expand Cerner Digital Record

    SAN DIEGO, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Longtime Cerner client Sharp HealthCare, a ...

    author_avatar
    NASDAQ Market News

    Flexion Therapeutics Reports Third-Quarter 2019 Financial Results and Recent Business Highlights

    author_avatar
    NASDAQ Market News